Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Salinas
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Salinas, CA

Studies commonly pay $75 to $4,500 per completed study

43 clinical trials are currently recruiting participants within 30 miles of Salinas. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

43studies recruiting
8+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Salinas right now

Top 25 of 43 recruiting studies, sorted by proximity — each links to its official registry page

Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease

Diabetic Kidney Disease (DKD) Phase 2 Interventional 270 participants sought
Central Coast Nephrology — Salinas, California (1.5 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07271186)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Dominican Santa Cruz Hospital — Santa Cruz, California (29.6 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

End Stage Kidney Disease Phase 2, Phase 3 Interventional 3,110 participants sought
Central Coast Nephrology Medical Corp — Salinas, California (1.5 mi) · Sponsor: CSL Behring
See eligibility & contact on ClinicalTrials.gov (NCT05485961)

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

Breast Cancer, Early Breast Cancer Phase 3 Interventional 5,500 participants sought
Research Site — Monterey, California (15.8 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT05952557)

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06580314)

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Phase 3 Interventional 364 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04510597)

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Breast Cancer Phase 3 Interventional 4,220 participants sought
Pacific Cancer Care - Oncology — Monterey, California (15.8 mi) · Sponsor: Stemline Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06492616)

Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

Anxiety, Mood Disorders N/A Interventional 156 participants sought
Ohana Center for Child and Adolescent Behavioral Health — Monterey, California (15.8 mi) · Sponsor: Stanford University
See eligibility & contact on ClinicalTrials.gov (NCT07155707)

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Phase 2 Interventional 56 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06031688)

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Cardiovascular Disease Phase 3 Interventional 15,100 participants sought
Research Site — Castroville, California (8.8 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07000357)

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Phase 2 Interventional 66 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05642572)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought
Salinas Valley Memorial — Salinas, California (1.5 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05879926)

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Multiple Myeloma Phase 1 Interventional 134 participants sought
Pacific Cancer Care — Monterey, California (15.8 mi) · Sponsor: Oncotherapeutics
See eligibility & contact on ClinicalTrials.gov (NCT03110822)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC) Phase 3 Interventional 1,040 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06661720)

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Arrhythmia, Bradycardia N/A Observational 20,000 participants sought
Research site — Salinas, California (1.5 mi) · Sponsor: Medtronic
See eligibility & contact on ClinicalTrials.gov (NCT00271180)

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma Phase 3 Interventional 382 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05677490)

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenosquamous Carcinoma Phase 2 Interventional 152 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04858334)

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Phase 3 Interventional 94 participants sought
Palo Alto Medical Foundation-Santa Cruz — Santa Cruz, California (29.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06998940)

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought
Salinas Valley Memorial — Salinas, California (1.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05812807)

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer N/A Observational 130 participants sought
Pacific Cancer Care — Monterey, California (15.8 mi) · Sponsor: N-Power Medicine
See eligibility & contact on ClinicalTrials.gov (NCT07028489)
Actively enrolling

Studies you may be able to join near Salinas

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Salinas

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Natividad Medical Center

★ 4.2
1441 Constitution Blvd, Salinas, CA 93906
(831) 755-4111

Clinica de Salud del Valle de Salinas- Sanborn

★ 1.8
219 N Sanborn Rd, Salinas, CA 93905
(831) 757-1365
"Terrible service, they never attend to you at your appointment time, sometimes even an hour late, plus the wait time in the waiting room and the room…"
— palemon cuellar, 1★

Lumos Clinical Research Center

★ 4.9
2516 Samaritan Dr Ste b, San Jose, CA 95124
(408) 402-5424
"This is my first clinical trial experience and I look forward to many more with Lumos. They have the friendliest staff, they made me feel welcome and…"
— Soso Happy, 5★

San Jose Clinical Trials

★ 4.9
2211 Moorpark Ave #275, San Jose, CA 95128
(408) 443-3540
"Very professional and pleasant atmosphere plus informational"
— Zan Cortner, 5★

UCSF ALS Center at Monterey

2 Upper Ragsdale Dr, Monterey, CA 93940
(415) 353-2122

ARCpoint Labs of Monterey Bay

★ 4.9
24560 Silver Cloud Ct #103, Monterey, CA 93940
(831) 324-0772
"David did an amazing job with my husband’s draw. He is very experienced and good natured."
— Laura Lamison, 5★

Pacific Cancer Care

★ 4.9 (190 reviews)
5 Harris Ct Bldg T Suite 201, Monterey, CA 93940
(831) 375-4105
"Dr. Tray has been with me the last 6 years of healing. She is personable and takes time to explain in detail of what's going occur."
— Karen Enea, 5★

Naval Postgraduate School

★ 4.7
1 University Circle, Monterey, CA 93943
(831) 656-2442
"I always go here after our Monterey aquarium visits or beach or during the old days at Dennis the menace park. We go gas up here if you have base acc…"
— Peter Davis, 5★

Clinical trials in Salinas: what's recruiting

The Salinas area currently has 43 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Salinas, the most active research areas are:

  • Cancer & Oncology18 studies
  • Liver & Kidney5 studies
  • Heart & Vascular3 studies
  • Brain & Mental Health2 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Salinas, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Salinas

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Salinas participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Salinas?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Salinas safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Salinas?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Salinas.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Salinas typically complete one or two studies per year.

Paid clinical trials near Salinas

Other metros within reach

Santa Cruz, CA164 San Jose, CA1,134 Sunnyvale, CA1,166 Fremont, CA2,256 Hayward, CA2,268 Modesto, CA98 Oakland, CA2,257 Antioch, CA451

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Salinas Bladder Issues Due To Spinal Cord Injury in Salinas All conditions

More of CA

Long Beach3,361 Torrance3,253 Fullerton3,246 Anaheim3,181 Garden Grove3,176 Pomona3,138 Glendale2,959 Los Angeles2,949 Huntington Beach2,863 Santa Clarita2,390 Hayward2,268 Oakland2,257

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts